Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis : Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor

Copyright © 2018 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 194(2018) vom: 01. Sept., Seite 9-18
1. Verfasser: Zhang, Yujuan (VerfasserIn)
Weitere Verfasser: Gupta, Saloni, Ilstad-Minnihan, Alexandra, Ayyangar, Sashi, Hay, Arielle D, Pascual, Virginia, Ilowite, Norman T, Macaubas, Claudia, Mellins, Elizabeth D
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Juvenile arthritis Monocytes;cytokine Interleukin-1 Interleukin-1beta Recombinant Fusion Proteins STAT1 Transcription Factor Suppressor of Cytokine Signaling 1 Protein mehr... rilonacept 8K80YB5GMG